Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with
the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Charcoal Formoterol Fumarate